Skip to search formSkip to main contentSkip to account menu

buame

Known as: N-(3-hydroxy-1,3,5(10)-estratrien-17beta-yl)butylamine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Estradiol Congeners

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
In vivo and in vitro evaluation of the estrogenic properties of the 17 b-( butylamino )-1 , 3 , 5 ( 10 )-estratrien-3-ol ( buame ) related to 17 b-estradiol
Background: Buame [17b-(butylamino)-1,3,5(10)-estratrien-3-ol] possesses anticoagulant and antiplatelet activities that are… 
2012
2012
The structures and inhibitory effects of Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N′-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine] on platelet…
2012
2012
In vivo and in vitro evaluation of the estrogenic properties of the 17β-(butylamino)-1, 3, 5(10)-estratrien-3-ol (buame) related to 17β-estradiol
2009
2009
Platelet aggregation in whole blood, a new approach for understanding the antiplatelet effect of N-(3-hydroxy-1,3,5(10)-estratrien-17b-yl) butylamine (buame).
We have previously reported the effect of a compound derived from estradiol containing a radical amino butyl at the 17-beta… 
1993
1993
Comparative effect of synthetic aminoestrogens with estradiol on platelet aggregation
1992
1992
Synthesis and uterotrophic activity of two novel amino-oestrogens : buame und proacame
1991
1991
The effects of five new 17 beta-amino-estrogens, buame, endiame, etolame, picae, and procame on blood clotting time.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)